Pharm Plan Minutes 2020.10.22

Meeting details =

Location

Morning login for Teams

Afternoon login for Teams

Minutes

Attendees:

• Leonidas
• Stephane
• Esther
• Michael
• Marc
• Jose

10:00-11:00 Opening and Committee work

• Review Agenda
  • Agenda not changed

• Review previous meeting notes
  • Corrected ( Oliver).

• Schedule

• Current version: Schedule 2020-2021

• Review and update Wiki

• General
• Roadmap
• Strategic goals

• Profile status discussion (public comment, final text, deprecated)

• Which profiles profiles could be set to "Final text"? Candidates? Criteria?

• Candidates for Final Text are:
  • PRE, DIS, PADV PML
  • But here has not enough testing. The results in 2019 with the new profiles are only from North America 2019 connectathon.
  • We decide to postpone to give the status of final text until we have more results from Connectathon. Probably until 2022
  • What is the status of the ELGA users? Is that only trial implementation?

11:15 - 12:00 Marcom & Promotion

• Feedback from IHE Board meeting
  • Board report has been reported.
  • Comment:
    • Overview of countries and relation to which IHE profiles each country uses
    • The reported was appreciated.
    • Discussion about the HL7 about the product identification.
    • Topic will be further discussed during the supply topic

How to attract more people to IHE Pharmacy

• Possible leads are the popular tracks:
  • supply
    • people are hesitating to join, because FHIR tools and methods are not clear for IHE profiles.
    • Also looking for backing at the IHE Europe sessions.
    • Looking for topics for November and December sessions.
    • One example are National incentives in Austria, Switzerland, Netherlands.
    • PATH has joined IHE, because HL7 is not really interested in supply. IHE Pharmacy does want to pick this up.
    • IHE will add workflows, which HL7 does not describe.
    • Hospitals are still pondering how to use FHIR. We could advise hospitals with this topic.

• • roll out in Switzerland. FHIR topics.
    • Stephane will promote our team during projectathon and call for volunteers.
    • Companies like HCI, they are reponsible for the pharmacy environment.
    • What about Oliver Egger? Or HL7 Switzerland. If Switzerland is moving from CDA to FHIR then it is important to give feedback about their experience back to IHE Pharmacy.
    • The projectathon organized a projectathon cafe, where Pharmacy was promoted.

• • Finding new topics with broad interest such as Vaccination?

• Broadcast our message from IHE Pharmacy
• Webinar series short topics.

16:00 - 18:00 Supply topics

• From the Whitepaper the group has set up the logical models.
• These artificats need a product resource, but in FHIR there are multiple candidates.
  • this could be a device, medication. We are searching for a common product pattern.
  • in the current use case of supply the physical product is the lowest level, for example a manufactured drug, or an electronic device.
  • the discussion within HL7 did not result in a workable solution. IHE Pharmacy has escalated the issue to board level. The suggestion was to organize a JIC to find a solution. This has neen diverted to a Gemini project.
  • Why not start with the requirements for a product in the context of supply and compare the various FHIR resources
  • We cannot wait until the JIC come with a decision. Should continue with use cases you have in supply and look for the best fit of FHIR resources that can be used as product.

• IHE Pharmacy has a suggestion to set up a new FHIR resource for inventory report
  • category should not be 0 to many instead 0 to 1. (narcotics, cold storage item)

• Next step is to publish the transactions in IHE.
  • the transaction will be traditional push messages.
  • what would be a potential market for the use of FHIR
  • Leonidas : associations of manufacturers, associations of managers, associations of hospital pharmacist.

Pharmacy Planning Committee